Inventor · disambiguated record
Hiroshi Nishimasu
Also filed as: NISHIMASU HIROSHI
12 granted patents·8 pending applications·48 citations·filing 2014–2023
86Inventor score
Top patents by PatentIndex Score
20 records- 0194US11578312B2Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulationBROAD INST INC·Filed 2017·Granted Feb 14, 2023·14 cites·27 claims
- 0294US10550372B2Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systemsBROAD INST INC·Filed 2016·Granted Feb 4, 2020·28 cites·36 claims
- 0386US11597919B2Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systemsBROAD INST INC·Filed 2019·Granted Mar 7, 2023·2 cites·30 claims
- 0480US12258595B2Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systemsBROAD INST INC·Filed 2022·Granted Mar 25, 2025·0 cites·30 claims
- 0577US12168789B2Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulationBROAD INST INC·Filed 2023·Granted Dec 17, 2024·0 cites·25 claims
- 0674US10189843B2Fused pyrazole derivative having autotaxin inhibitory activityUNIV TOKYO·Filed 2015·Granted Jan 29, 2019·3 cites·11 claims
- 0771US12152259B2Modified CAS9 protein, and use thereofUNIV TOKYO·Filed 2022·Granted Nov 26, 2024·0 cites·15 claims
- 0870US2024035006A1Crystal structure of crispr cpf1BROAD INST INC·Filed 2022·Application pending·0 cites
- 0969US10183949B2Pyrimidinone derivative having autotaxin-inhibitory activityUNIV TOKYO·Filed 2017·Granted Jan 22, 2019·1 cites·16 claims
- 1067US11702645B2Polynucleotide encoding modified CAS9 proteinUNIV TOKYO·Filed 2022·Granted Jul 18, 2023·0 cites·8 claims
- 1166US2023383288A1Systems, methods, and compositions for rna-guided rna-targeting crispr effectorsMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Application pending·0 cites
- 1265US2024229023A9Rna-triggered protein cleavage and applications by the crispr cas7-11-csx29 complexMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Application pending·0 cites
- 1358US11530396B2Modified CAS9 protein, and use thereofUNIV TOKYO·Filed 2018·Granted Dec 20, 2022·0 cites·25 claims
- 1457US2020080067A1Crispr-cas systems, crystal structure and uses thereofBROAD INST INC·Filed 2019·Application pending·0 cites
- 1556US11155795B2CRISPR-Cas systems, crystal structure and uses thereofBROAD INST INC·Filed 2016·Granted Oct 26, 2021·0 cites·6 claims
- 1655US11371030B2Modified Cas9 protein and use thereofUNIV TOKYO·Filed 2018·Granted Jun 28, 2022·0 cites·16 claims
- 1750US2025340854A1ENGINEERED Cas12f PROTEINUNIV TOKYO·Filed 2021·Application pending·0 cites
- 1844US2019264186A1Crystal structure of crispr cpf1BROAD INST INC·Filed 2017·Application pending·0 cites
- 1941US2016002247A18-substituted imidazopyrimidinone derivative having autotaxin inhibitory activityUNIV TOKYO·Filed 2014·Application pending·0 cites
- 2037US2018201912A1Modified fncas9 protein and use thereofUNIV TOKYO·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hiroshi Nishimasu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →